United Biotech Private LimitedUnited Biotech Private Limited

Site Search:


Home Profile Products Contact Us

Products

Critical Care Division

Specialty Division

Oncology Division

Copas Division

Hygea Division

Rinon Division

Piperacillin and Tazobactam for Injection 2.25 g and 4.5 g

Essential Amino Acids Tablets

Calcium Polystyrene Sulphonate Powder 15 g

Metolazone Tablets USP 2.5 mg

Metolazone Tablets USP 5 MG

Lyophilized Methylprednisolone Sodium Succinate 500MG

Lyophilized Methylprednisolone Sodium Succinate 1G

Cyclosporine Injection USP 50 mg/ml

Cyclosporine Injection USP 250 mg/5ml

Cyclosporine Capsules USP 25 mg

Cyclosporine Capsules USP 50 mg

Cyclosporine Capsules USP 100 MG

Cyclosporine Oral Solution USP 100 mg

Meropenem For Injection USP 500 mg

Meropenem For Injection USP 1 g

Mycophenolate Mofetil Tablets 250 MG

Mycophenolate Mofetil Tablets 500 MG

Mycophenolate Sodium Tablets 180 MG

Mycophenolate Sodium Tablets 360 MG

Tacrolimus Capsules 0.5 mg

Tacrolimus Capsules 1 mg

Tacrolimus Capsules 5 mg

Azathioprine Tablets USP 50 mg

Prazosin Tablets BP 1 MG

Prazosin Tablets BP 2 MG

Iron Sucrose Injection USP 50 MG/ 2.5 ML

Iron Sucrose Injection USP 100 MG/ 5.0 ML

Terazosin Hydrochloride Tablets 1 MG

Terazosin Hydrochloride Tablets 2 MG

Vancomycin Hydrochloride For Injection USP 500 MG

Vancomycin Hydrochloride For Injection USP 1.0 g

Pharmaceutical Products

Pharmaceutical Injectables


Rinon Division

Share: FacebookTwitterStumble

Our range of products include Rinon Division such as Essential Amino Acids Tablets, Calcium Polystyrene Sulphonate Powder 15 g, Metolazone Tablets USP 2.5 mg, Metolazone Tablets USP 5 mg, Lyophilized Methylprednisolone Sodium Succinate 500mg, Lyophilized Methylprednisolone Sodium Succinate 1g and many more items.

Piperacillin and Tazobactam for Injection 2.25 g and 4.5 g

Piperacillin and Tazobactam for Injection 2.25 g and 4.5 g



Indications :

  • Appendicitis and Peritonitis  
  • Uncomplicated and complicated skin and soft tissue infections  
  • Pelvic inflammatory diseases  
  • Community acquired pneumonia 
  • Nosocomial pneumonia due to S. aureus

Dosage :  

Children >12 years and Adults :

Nosocomial pneumonia:
I.V. : Piperacillin / tazobactam 4.5 g every 6 hours for 7-14 days.

Severe infections :  
I.V. : Piperacillin / tazobactam 4.5g every 8 hours or 3/0.375 g every 6 hours for 7-10 days.

Moderate infections : 
I.M. : Piperacillin / tazobactam 2.25g every 6-8 hours; treatment should be continued for 7-10 days depending on severity of disease.

Paediatric :

  • 112.50mg/kg TID (age 9 months or older).  
  • 90mg/kg TID (age 2months - 9months).

Dosage Adjustment :

Renal Impairment : Required.

Hepatic Impairment : Administer with caution

Packing :
2.5 g 1 Vials of 2.25 g
4.5 g 1 Vials of 4.5 g

Essential Amino Acids Tablets

Indications :

  • Chronic Glomerulonephritis 
  • Chronic Pyelonephritis 
  • Polycystic Kidney Disease 
  • Pre, Post and during Dialysis 
  • As a Maintenance Therapy

Dosage :

If the protein content in the diet is reduced gradually, dosage of Aminos is increased simultaneously.

Dosage Adjustment
Renal Impairment : Administer with caution.
Hepatic Impairment : 
Administer with caution.

Packing :3 Strips of 10 Tablets 
Essential Amino Acids Tablets



Calcium Polystyrene Sulphonate Powder 15 g

Calcium Polystyrene Sulphonate Powder 15 g



Indications :

  • Hyperkalemia associated anuria or severe oliguria 
  • Hyperkalemia due to acute & chronic renal failure
  • Patients requiring dialysis

Dosage :

Adults : 15g 3-4 times a day as a suspension in a small amount of water (3-4 ml/gm of resin).

Children :
 Initial - 1g/kg body wt. daily in divided doses.
Maintenance - 0.5g/kg body wt. in divided doses.

Dosage Adjustment

Renal Impairment : Not required, administer with caution.
Hepatic Impairment : 
Not required, administer with caution.

Packing : 10 Sachets of 15g 

Metolazone Tablets USP 2.5 mg

Indications :

  • Edema accompanying renal diseases, including the nephrotic syndrome and states of diminished renal function 
  • Hypertension (alone or in combination with other antihypertensive drugs of a different class.) 
  • Edema accompanying congestive heart failure

Dosage Adjustment

Renal Impairment :
 May be required. 
Hepatic Impairment : 
May be required.

Packing :  10 Strips of 10 Tablets
Metolazone Tablets USP 2.5 mg



Metolazone Tablets USP 5 MG

Metolazone Tablets USP 5 MG



Indications :

  • Edema accompanying renal diseases, including the nephrotic syndrome and states of diminished renal function 
  • Hypertension (alone or in combination with other antihypertensive drugs of a different class.) 
  • Edema accompanying congestive heart failure

Dosage Adjustment

Renal Impairment :
 May be required.
Hepatic Impairment : 
May be required.

Packing : 10 Strips of 10 Tablets   

Lyophilized Methylprednisolone Sodium Succinate 500MG

Indications :

Neurological Conditions :

Multiple Sclerosis, Spinal Cord Injury, Cerebral injury

Nephrological Conditions :

Glomerular nephritis and Lupus nephritis

Dosage :

In Multiple Sclerosis

1g/day I.V. for 3-5 days.

In Optic Neuritis

1g/day I.V. for 3 days followed by oral prednisolone therapy.

In Renal transplantation

  • For induction of Immunosuppression : Start with 80-160 mg OD for three days followed by oral therapy.
  • In treatment of acute rejection: 500 mg upon diagnosis, followed by 500 mg OD for two days.

Oedematous states


30 mg/kg body weight every other day for 4 days or 1gm /day for 3, 5 or 7 days I.V. 

Acute Spinal cord injury 


30 mg /kg bolus followed by 5.4 mg/kg bolus for 24-48 hours.

Prevention of ARDS and Fat Embolism syndrome 

30 mg /kg body weight can be repeated after 6 hours.


Packing :  1 Vial of 500mg
Lyophilized Methylprednisolone Sodium Succinate 500MG



Lyophilized Methylprednisolone Sodium Succinate 1G

Lyophilized Methylprednisolone Sodium Succinate 1G



Indications :

Neurological Conditions :

Multiple Sclerosis, Spinal Cord Injury, Cerebral injury

Nephrological Conditions :

Glomerular nephritis and Lupus nephritis

Dosage :

In Multiple Sclerosis

1g/day I.V. for 3-5 days. 

In Optic Neuritis


1g/day I.V. for 3 days followed by oral prednisolone therapy. 

In Renal transplantation


  • For induction of Immunosuppression : Start with 80-160 mg OD for three days followed by oral therapy.
  • In treatment of acute rejection: 500 mg upon diagnosis, followed by 500 mg OD for two days.

Oedematous states


30 mg/kg body weight every other day for 4 days or 1gm /day for 3, 5 or 7 days I.V. 

Acute Spinal cord injury

 
30 mg /kg bolus followed by 5.4 mg/kg bolus for 24-48 hours. 

Prevention of ARDS and Fat Embolism
syndrome 


30 mg /kg body weight can be repeated after 6 hours.

Packing :   1 Vial of 1g 

Cyclosporine Injection USP 50 mg/ml

Indications :

  • In prophylaxis of organ rejection 
  • Kidney transplant 
  • Liver Transplant 
  • Heart Transplant 

Dosage :  

Initial Oral Dose : 15 mg/kg OD dose 4-12 hrs prior to transplantation.

Pediatric Dose : 2 mg/kg/day for the first 4 days tapered to 1 mg/kg/day by 1 week, 0.6 mg/kg/day by 2 weeks, 0.3 mg/kg/day by 1 month and 0.15 mg/kg/day by 2 months.

Dosage Adjustment :

Renal Impairment : Required.

Hepatic Impairment : Probably necessary, administer with caution. 

Packing :   10 Ampoules of 1 ml
Cyclosporine Injection USP 50 mg/ml



Cyclosporine Injection USP 250 mg/5ml

Cyclosporine Injection USP 250 mg/5ml



Indications :

  • In prophylaxis of organ rejection 
  • Kidney transplant 
  • Liver Transplant 
  • Heart Transplant 

Dosage :  

Initial Oral Dose : 15 mg/kg OD dose 4-12 hrs prior to transplantation.

Pediatric Dose : 
2 mg/kg/day for the first 4 days tapered to 1 mg/kg/day by 1 week, 0.6 mg/kg/day by 2 weeks, 0.3 mg/kg/day by 1 month and 0.15 mg/kg/day by 2 months.

Dosage Adjustment :

Renal Impairment : Required.

Hepatic Impairment : 
Probably necessary, administer with caution. 

Packing :    5 Ampoules of 5 ml

Cyclosporine Capsules USP 25 mg

Indications :

  • In prophylaxis of organ rejection 
  • Kidney transplant 
  • Liver Transplant 
  • Heart Transplant 

Dosage :  

Initial Oral Dose : 15 mg/kg OD dose 4-12 hrs prior to transplantation.

Pediatric Dose : 
2 mg/kg/day for the first 4 days tapered to 1 mg/kg/day by 1 week, 0.6 mg/kg/day by 2 weeks, 0.3 mg/kg/day by 1 month and 0.15 mg/kg/day by 2 months.

Dosage Adjustment :

Renal Impairment : Required.

Hepatic Impairment : 
Probably necessary, administer with caution. 

Packing :     3 Strips of 10 Capsules
Cyclosporine Capsules USP 25 mg



Cyclosporine Capsules USP 50 mg

Cyclosporine Capsules USP 50 mg



Indications :

  • In prophylaxis of organ rejection 
  • Kidney transplant 
  • Liver Transplant 
  • Heart Transplant 

Dosage :  

Initial Oral Dose : 15 mg/kg OD dose 4-12 hrs prior to transplantation.

Pediatric Dose : 
2 mg/kg/day for the first 4 days tapered to 1 mg/kg/day by 1 week, 0.6 mg/kg/day by 2 weeks, 0.3 mg/kg/day by 1 month and 0.15 mg/kg/day by 2 months.

Dosage Adjustment :

Renal Impairment : Required.

Hepatic Impairment : 
Probably necessary, administer with caution. 

Packing :      5 Strips of 6 Capsules

Cyclosporine Capsules USP 100 MG

Indications :

  • In prophylaxis of organ rejection 
  • Kidney transplant 
  • Liver Transplant 
  • Heart Transplant 

Dosage :  

Initial Oral Dose : 15 mg/kg OD dose 4-12 hrs prior to transplantation.

Pediatric Dose : 
2 mg/kg/day for the first 4 days tapered to 1 mg/kg/day by 1 week, 0.6 mg/kg/day by 2 weeks, 0.3 mg/kg/day by 1 month and 0.15 mg/kg/day by 2 months.

Dosage Adjustment :

Renal Impairment : Required.

Hepatic Impairment : 
Probably necessary, administer with caution. 

Packing :      5 Strips of 6 Capsules
Cyclosporine Capsules USP 100 MG



Cyclosporine Oral Solution USP 100 mg

Cyclosporine Oral Solution USP 100 mg



Indications :

  • In prophylaxis of organ rejection 
  • Kidney transplant 
  • Liver Transplant 
  • Heart Transplant 

Dosage :  

Initial Oral Dose : 15 mg/kg OD dose 4-12 hrs prior to transplantation.

Pediatric Dose : 
2 mg/kg/day for the first 4 days tapered to 1 mg/kg/day by 1 week, 0.6 mg/kg/day by 2 weeks, 0.3 mg/kg/day by 1 month and 0.15 mg/kg/day by 2 months.

Dosage Adjustment :

Renal Impairment : Required.

Hepatic Impairment : 
Probably necessary, administer with caution. 

Packing :    1 Bottle of 50 ml

Meropenem For Injection USP 500 mg

Indications :

  • Peritoneal dialysis associated peritonitis.
  • Post transplant infection with Paeruginosa, Staph aureus and Klebsiella. 
  • Post transplant Urinary tract infection. 
  • Post transplant Respiratory tract infection. 
  • Bacterial sepsis associated with renal transplant. 
  • Post transplant nocardial infection. 
  • As prophylaxis in transplant surgery.

Dosage :The recommended dosages of Meropenem are : 

Intra-abdominal infections :

IV 1g every 8 hours (adults)
IV 20mg/kg every 8 h (children) 
2g every 8 h (Max. dose) 

Meningitis :

IV 40 mg/kg every 8 h (children above 3 mths of age)
2g every 8 h (Max. dose) 

Skin and skin inflammation :

IV 500mg evry 8 h (adults)  
IV 10mg/kg every 8 h (children above 3 mths of age) 
500mg every 8 h (max. dose) 

Dosage Adjustment : 

Renal Impairment : Required.

Hepatic Impairment : 
Not necessary.   

Packing :   10 Vials of 500 mg
Meropenem For Injection USP 500 mg



Meropenem For Injection USP 1 g

Meropenem For Injection USP 1 g



Indications :

  • Peritoneal dialysis associated peritonitis.
  • Post transplant infection with P.aeruginosa, Staph aureus and Klebsiella. 
  • Post transplant Urinary tract infection. 
  • Post transplant Respiratory tract infection. 
  • Bacterial sepsis associated with renal transplant. 
  • Post transplant nocardial infection. 
  • As prophylaxis in transplant surgery.

Dosage : The recommended dosages of Meropenem are : 

Intra-abdominal infections :

IV 1g every 8 hours (adults)
IV 20mg/kg every 8 h (children) 
2g every 8 h (Max. dose) 

Meningitis :

IV 40 mg/kg every 8 h (children above 3 mths of age)
2g every 8 h (Max. dose) 

Skin and skin inflammation :

IV 500mg evry 8 h (adults)  
IV 10mg/kg every 8 h (children above 3 mths of age) 
500mg every 8 h (max. dose) 

Dosage Adjustment :

Renal Impairment : Required.

Hepatic Impairment : Not necessary.   

Packing :    10 Vials of 1 g

Mycophenolate Mofetil Tablets 250 MG

Indications :
  • For the prophylaxis of organ rejection in patients receiving allogeneic renal, cardiac or hepatic transplants.

Dosage : 

Renal Transplantation :

Adults :
 A dose of 1 g administered orally twice a day (daily dose of 2 g) is recommended for use in renal transplant patients.

Pediatrics : 
Patients with a body surface area of 1.25 m² to 1.5 m² (3 months to 18 years) may be given a dose of 750 mg twice daily (1.5 g daily dose). Patients with a body surface area > 1.5 m² may be dosed with at a dose of 1 g twice daily (2 g daily dose).

Cardiac Transplantation :

Adults :
 A dose of 1.5g BID oral (daily dose of 3g) is recommended for use in adult cardiac transplant patients.

Hepatic Transplantation : 

Adults : 
A dose of 1.5g BID oral (daily dose of 3g) is recommended for use in adult cardiac transplant patients. 

Dosage Adjustment : 

Renal Impairment : 
Not required. 

Hepatic Impairment : 
May be required in renal patients with some hepatic diseases. 

Packing :  6 Strips of 10 Tablets
Mycophenolate Mofetil Tablets 250 MG



Mycophenolate Mofetil Tablets 500 MG

Mycophenolate Mofetil Tablets 500 MG



Indications :

  • For the prophylaxis of organ rejection in patients receiving allogeneic renal, cardiac or hepatic transplants.

Dosage : 

Renal Transplantation :

Adults : A dose of 1 g administered orally twice a day (daily dose of 2 g) is recommended for use in renal transplant patients.

Pediatrics : Patients with a body surface area of 1.25 m² to 1.5 m² (3 months to 18 years) may be given a dose of 750 mg twice daily (1.5 g daily dose). Patients with a body surface area > 1.5 m² may be dosed with at a dose of 1 g twice daily (2 g daily dose).

Cardiac Transplantation :

Adults : A dose of 1.5g BID oral (daily dose of 3g) is recommended for use in adult cardiac transplant patients.

Hepatic Transplantation :

Adults : 
A dose of 1.5g BID oral (daily dose of 3g) is recommended for use in adult cardiac transplant patients. 

Dosage Adjustment : 

Renal Impairment : 
Not required.
 
Hepatic Impairment : 
May be required in renal patients with some hepatic diseases. 

Packing :  6 Strips of 10 Tablets

Mycophenolate Sodium Tablets 180 MG

Indications :

  • For the prophylaxis of organ rejection in patients receiving allogeneic renal, cardiac or hepatic transplants.

Dosage :

Adults : The recommended doses is 720 mg administered twice daily (1440 mg total daily dose) on an empty stomach, one hour before or two hours after food intake.

Pediatrics : Based on a pharmacokinetic study conducted in stable renal pediatric transplant patients, the recommended dose in stable pediatric patients is 400 mg/m² body surface area (BSA) administered twice daily (up to a maximum dose of 720 mg administered twice daily). Patients with a BSA of 1.19 to 1.58 m² may be dosed either with three 180 mg tablets or one 180 mg plus one 360 mg tablet twice daily (1080 mg daily dose).  

Dosage Adjustment :

Renal Impairment : Not required.

Hepatic Impairment : May be required in renal patients with some hepatic diseases.

Packing :   6 Strips of 10 Tablets
Mycophenolate Sodium Tablets 180 MG



Mycophenolate Sodium Tablets 360 MG

Mycophenolate Sodium Tablets 360 MG



Indications :

  • For the prophylaxis of organ rejection in patients receiving allogeneic renal, cardiac or hepatic transplants.

Dosage :

Adults :
 The recommended doses is 720 mg administered twice daily (1440 mg total daily dose) on an empty stomach, one hour before or two hours after food intake.

Pediatrics : 
Based on a pharmacokinetic study conducted in stable renal pediatric transplant patients, the recommended dose in stable pediatric patients is 400 mg/m² body surface area (BSA) administered twice daily (up to a maximum dose of 720 mg administered twice daily). Patients with a BSA of 1.19 to 1.58 m² may be dosed either with three 180 mg tablets or one 180 mg plus one 360 mg tablet twice daily (1080 mg daily dose).  

Dosage Adjustment :

Renal Impairment : Not required.

Hepatic Impairment : 
May be required in renal patients with some hepatic diseases.

Packing :   6 Strips of 10 Tablets

Tacrolimus Capsules 0.5 mg

Indications :

  • Prophylaxis of organ rejection in patients receiving allogeneic organ transplants.

Dosage Adjustment :

Renal Impairment :
 Administer with caution.

Hepatic Impairment : 
Needs adjustment.

Packing :  5 Strips of 10 Capsules
Tacrolimus Capsules 0.5 mg



Tacrolimus Capsules 1 mg

Tacrolimus Capsules 1 mg



Indications :

  • Prophylaxis of organ rejection in patients receiving allogeneic organ transplants.  

Dosage Adjustment :

Renal Impairment :
 Administer with caution. 

Hepatic Impairment : 
Needs adjustment.  


Packing :  5 Strips of 10 Capsules

Tacrolimus Capsules 5 mg

Indications :

  • Prophylaxis of organ rejection in patients receiving allogeneic organ transplants.  

Dosage Adjustment :

Renal Impairment :
 Administer with caution. 

Hepatic Impairment : 
Needs adjustment.  


Packing :  5 Strips of 10 Capsules
Tacrolimus Capsules 5 mg



Azathioprine Tablets USP 50 mg

Azathioprine Tablets USP 50 mg



Indications :

  • As an adjunct in the prevention of rejection in renal and solid organ transplantation.
  •  Management of severe rheumatoid arthritis. 

Autoimmune diseases :


- Inflammatory bowel disease including moderate to severe crohn's disease.   
- Autoimmune hepatitis. 
- Systemic lupus erythematosus. 
- Multiple sclerosis. 

Dosage :  

Renal and solid organ transplantation :

Children and adults : 2-5 mg/kg/day to start at the time of transplant, then 1-3 mg/kg/day as a maintenance dose.

Rheumatoid arthritis and autoimmune disease :

Adults : 

Initial : 
1 mg/kg/day given once daily or divided twice daily 6-8 weeks; increase by 05 mg/kg every 4 weeks until response or up to 2.5 mg/kg/day.

Maintenance dose : Reduce dose by 0.5 mg/kg every 4 weeks unitl lowest effective dose is reached.


Dosage Adjustment :

Renal Impairment :
 Require adjustment.    

Hepatic Impairment : 
Administer with caution.

Packing :  10 Strips of 10 Tablets  
 

Prazosin Tablets BP 1 MG

Indications :
  • Benign prostatic hyperplasia.  
  • Hypertension.
  • Congestive heart failure.
  • Vasospastic therapy.
  • Raynaud's phenomenon in progressive systemic sclerosis.
Dosage :
Children : 50 to 400 mcg /Kg/Day in 2-3 divided doses. 

Dosage Adjustment :

Renal Impairment : May be required in severe impairment.
Hepatic Impairment : May be required in severe impairment.


Packing : 10 Strips of 10 Tablets
Prazosin Tablets BP 1 MG



Prazosin Tablets BP 2 MG

Prazosin Tablets BP 2 MG



Indications :
  • Benign prostatic hyperplasia.  
  • Hypertension.
  • Congestive heart failure.
  • Vasospastic therapy.
  • Raynaud's phenomenon in progressive systemic sclerosis.
Dosage :
Children : 50 to 400 mcg /Kg/Day in 2-3 divided doses. 

Dosage Adjustment :

Renal Impairment : May be required in severe impairment.
Hepatic Impairment : May be required in severe impairment.


Packing : 10 Strips of 10 Tablets

Iron Sucrose Injection USP 50 MG/ 2.5 ML

Indications :
  • Pre existing (moderate to severe) anemia  
  • Patients not responding or having poor compliance with oral iron supplements
  • Pre and postoperative period
  • Postpartum anemia and postpartum haemorrhage
  • Patients with poor iron absorption (bowel operations or diseases)
  • Patients with severe renal impairment
Dosage :

The total cumulative dose of iron sucrose, equivalent to the total iron deficit (mg), is determined by the hemoglobin level and body weight. 

Adult : 100-200mg iron one-three times a week depending on the Hb level.
Children : 30mg/kg body wt. one-three times per week depending on the Hb level.

Dosage Adjustment :

Renal Impairment : Administer with caution in severe renal impairment.
Hepatic Impairment : Required.


Packing : 5 Ampoules of 2.5 ml 
Iron Sucrose Injection USP 50 MG/ 2.5 ML



Iron Sucrose Injection USP 100 MG/ 5.0 ML

Iron Sucrose Injection USP 100 MG/ 5.0 ML



Indications :
  • Pre existing (moderate to severe) anemia  
  • Patients not responding or having poor compliance with oral iron supplements
  • Pre and postoperative period
  • Postpartum anemia and postpartum haemorrhage
  • Patients with poor iron absorption (bowel operations or diseases)
  • Patients with severe renal impairment
Dosage :

The total cumulative dose of iron sucrose, equivalent to the total iron deficit (mg), is determined by the hemoglobin level and body weight. 

Adult : 100-200mg iron one-three times a week depending on the Hb level.
Children : 30mg/kg body wt. one-three times per week depending on the Hb level.

Dosage Adjustment :

Renal Impairment : Administer with caution in severe renal impairment.
Hepatic Impairment : Required.


Packing :  5 Ampoules of 5 ml

Terazosin Hydrochloride Tablets 1 MG

Indications :
  • Benign prostate hyperplasia (BPH) 
  • Management of mild to moderate hypertension 
  • BPH with concomitant cardiovascular diseases  
  • Expulsion of lower ureteral stones

Dosage :

Adults : Initial dose should not exceed 1 mg in any indication. If drug is discontinued for long duration, consider beginning with initial dose and retitrate as needed 
Benign prostatic hyperplasia :
Initial Dose : 1 mg at bedtime , gradually increasing the subsequent doses to 2 mg , 5 mg or 10 mg once daily up to a maximum of 20 mg/ day if no response after 4-6 weeks of 10 mg/day. 

Usual dose : 5-10 mg once daily.

Hypertension :
Initial Dose : 1 mg at bedtime; slowly increase dose to achieve desired blood pressure response, up to maximum of 20 mg/day.

Usual dose : 2-10 mg once daily
Dosage reduction may be needed when adding a diuretic or other antihypertensive agent; dosage may be given on a twice daily regimen if response is diminished at 24 hours and hypotensive is observed at 2-4 hours following a dose 

Dosage Adjustment :

Renal Impairment : Modification of dosage in such patients generally does not appear to be necessary.
Hepatic Impairment : Not well studied, administer with caution.


Packing :10 Strips of 10 Tablets 
Terazosin Hydrochloride Tablets 1 MG



Terazosin Hydrochloride Tablets 2 MG

Terazosin Hydrochloride Tablets 2 MG



Indications :
  • Benign prostate hyperplasia (BPH) 
  • Management of mild to moderate hypertension 
  • BPH with concomitant cardiovascular diseases  
  • Expulsion of lower ureteral stones

Dosage :

Adults : Initial dose should not exceed 1 mg in any indication. If drug is discontinued for long duration, consider beginning with initial dose and retitrate as needed 
Benign prostatic hyperplasia :
Initial Dose : 1 mg at bedtime , gradually increasing the subsequent doses to 2 mg , 5 mg or 10 mg once daily up to a maximum of 20 mg/ day if no response after 4-6 weeks of 10 mg/day. 

Usual dose : 5-10 mg once daily.

Hypertension :
Initial Dose : 1 mg at bedtime; slowly increase dose to achieve desired blood pressure response, up to maximum of 20 mg/day.

Usual dose : 2-10 mg once daily
Dosage reduction may be needed when adding a diuretic or other antihypertensive agent; dosage may be given on a twice daily regimen if response is diminished at 24 hours and hypotensive is observed at 2-4 hours following a dose 

Dosage Adjustment :

Renal Impairment : Modification of dosage in such patients generally does not appear to be necessary.
Hepatic Impairment : Not well studied, administer with caution.


Packing :10 Strips of 10 Tablets 

Vancomycin Hydrochloride For Injection USP 500 MG

Vancomycin Hydrochloride For Injection USP 500 mg (Lyophilized)
Indications :
  • Respiratory Tract Infections  
  • Endocarditis
  • Pseudomonas colitis
  • Prophylaxis in Surgery / Organ Transplant
Dosage :

Adult dose : The usual adult dose is the equivalent of 500 mg of vancomycin every 6 hours or 1 g every 12 hours.  
 Paediatric dose : 10 - 15 mg/kg every 8 hours.


Dosage Adjustment : 
Renal Impairment : Required.  
Hepatic Impairment : Required in severe impairment.  


Packing : 10 Vials of 500 mg
Vancomycin Hydrochloride For Injection USP 500 MG



Vancomycin Hydrochloride For Injection USP 1.0 g

Vancomycin Hydrochloride For Injection USP 1.0 g



Vancomycin Hydrochloride For Injection USP 1.0 g (Lyophilized)
Indications :
  • Respiratory Tract Infections  
  • Endocarditis
  • Pseudomonas colitis
  • Prophylaxis in Surgery / Organ Transplant
Dosage :

Adult dose : The usual adult dose is the equivalent of 500 mg of vancomycin every 6 hours or 1 g every 12 hours.  
 Paediatric dose : 10 - 15 mg/kg every 8 hours.


Dosage Adjustment : 
Renal Impairment : Required.  
Hepatic Impairment : Required in severe impairment.  


Packing : 10 Vials of 500 mg 

Contact Us

United Biotech Private Limited
Mr. Suresh Kumar / Mr. Sandeep / Mr. Gulab (International Marketing)
FC- B-1 Extension, Mohan Co- Operative Industrial Estate, Mathura Road,, New Delhi - 110 044, Delhi, India

Contact via E-mail

Contact via SMS


Home  |  Profile  |  Products  |  Trade Offers (10)   |  Site Map  |  Contact Us

Member IndiaMART.com © United Biotech Private Limited. All Rights Reserved (Terms of Use)
Developed and Managed by IndiaMART InterMESH Limited

Business Enquiry Form


(* represents compulsory fields )

*Describe Your Requirements in Detail
Please Fill Your Contact Information
*Contact Person:
*Email:
Company:
Street Address:
*Country:
*Telephone:
Mobile:
Website:
*Enter the code: